Literature DB >> 10642388

CO(2) homeostasis during periodic breathing in obstructive sleep apnea.

K I Berger1, I Ayappa, I B Sorkin, R G Norman, D M Rapoport, R M Goldring.   

Abstract

The contribution of apnea to chronic hypercapnia in obstructive sleep apnea (OSA) has not been clarified. Using a model (D. M. Rapoport, R. G. Norman, and R. M. Goldring. J. Appl. Physiol. 75: 2302-2309, 1993), we previously illustrated failure of CO(2) homeostasis during periodic breathing resulting from temporal dissociation between ventilation and perfusion ("temporal V/Q mismatch"). This study measures acute kinetics of CO(2) during periodic breathing and addresses interapnea ventilatory compensation for maintenance of CO(2) homeostasis in 11 patients with OSA during daytime sleep (37-171 min). Ventilation and expiratory CO(2) and O(2) fractions were measured on a breath-by-breath basis by means of a tight-fitting full facemask. Calculations included CO(2) excretion, metabolic CO(2) production, and CO(2) balance (metabolic CO(2) production - exhaled CO(2)). CO(2) balance was tabulated for each apnea/hypopnea event-interevent cycle and as a cumulative value during sleep. Cumulative CO(2) balance varied (-3,570 to +1,388 ml). Positive cumulative CO(2) balance occurred in the absence of overall hypoventilation during sleep. For each cycle, positive CO(2) balance occurred despite increased interevent ventilation to rates as high as 45 l/min. This failure of CO(2) homeostasis was dependent on the event-to-interevent duration ratio. The results demonstrate that 1) periodic breathing provides a mechanism for acute hypercapnia in OSA, 2) acute hypercapnia during periodic breathing may occur without a decrease in average minute ventilation, supporting the presence of temporal V/Q mismatch, as predicted from our model, and 3) compensation for CO(2) accumulation during apnea/hypopnea may be limited by the duration of the interevent interval. The relationship of this acute hypercapnia to sustained chronic hypercapnia in OSA remains to be further explored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642388     DOI: 10.1152/jappl.2000.88.1.257

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  20 in total

1.  Overnight Transcutaneous Carbon Dioxide Monitoring in Eucapnic Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Banu Salepci; Ali Fidan; Benan Çağlayan; Elif Parmaksız; Ülkü Aktürk; Nesrin Kıral; Sevda Şener Cömert; Gülşen Saraç; Egehan Salepçi
Journal:  Turk Thorac J       Date:  2014-11-05

2.  Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients.

Authors:  Gul Gursel; Avsar Zerman; Burcu Basarik; Kamil Gonderen; Muge Aydogdu; Serriyye Memmedova
Journal:  Intern Emerg Med       Date:  2018-03-06       Impact factor: 3.397

3.  Characterization of acid signaling in rat vagal pulmonary sensory neurons.

Authors:  Qihai Gu; Lu-Yuan Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-01-27       Impact factor: 5.464

4.  Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece.

Authors:  Georgia Periklis Trakada; Paschalis Steiropoulos; Evangelia Nena; Theodoros C Constandinidis; Demosthenes Bouros
Journal:  Sleep Breath       Date:  2010-05-22       Impact factor: 2.816

Review 5.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

6.  Polysomnographic determinants of nocturnal hypercapnia in patients with sleep apnea.

Authors:  Nattapong Jaimchariyatam; Raed A Dweik; Roop Kaw; Loutfi S Aboussouan
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

7.  Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig.

Authors:  Marian Kollarik; Bradley J Undem
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 8.  Clinical consequences of altered chemoreflex control.

Authors:  Maria Plataki; Scott A Sands; Atul Malhotra
Journal:  Respir Physiol Neurobiol       Date:  2013-05-13       Impact factor: 1.931

Review 9.  Upper airway mechanics.

Authors:  Johan A Verbraecken; Wilfried A De Backer
Journal:  Respiration       Date:  2009-05-29       Impact factor: 3.580

10.  Eszopiclone prevents excitotoxicity and neurodegeneration in the hippocampus induced by experimental apnea.

Authors:  Simon J Fung; Ming-Chu Xi; Jian-Hua Zhang; Jack Yamuy; Sharon Sampogna; Kevin L Tsai; Vincent Lim; Francisco R Morales; Michael H Chase
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.